Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2006

View Archived Issues

CE Mark for Tag-It Cystic Fibrosis Kit

ActivBiotics and Metaphore Pharmaceuticals complete merger

Pharmacopeia earns milestone payment in Organon collaboration

New multidose study of Riquent planned in lupus patients

Studies show BioThrax plus antibiotics protect animals post anthrax exposure

Japanese licensing deal for Fentanyl Taifun

Corautus Genetics to support study of VEGF-2 in critical limb ischemia

Salix offers development update

Duloxetine 60 mg once daily found safe and effective in fibromyalgia patients

GE-81112 factor B: A novel prokaryotic-specific protein synthesis inhibitor

Human Genome Sciences receives milestone for GSK-716155 IND filing

Mylan and Forest sign nebivolol agreement

Ablynx and Centocor sign Nanobodies agreement

Phase IIa study of ATL-1102 restarts

Safety data review in phase III study of Intercell's Japanese encephalitis vaccine

Russian approvals for HER-2 Protein AutoVac vaccine phase II trial

Placebo group assumptions correct in phase IIb study of VLTS-934 in intermittent claudication

Novel orally active CB1 receptor inverse agonist decreases food intake in rodents

Novel orally active and in vivo effective p38alpha MAPK inhibitors from Novartis

FDA issues guidance to improve efficiency of earliest stages of clinical testing

Recent patents report novel therapeutic agents for anxiety, depression, etc.

Novel possible treatment options for cancer disclosed in patent literature

First launch for Dong-A erectile dysfunction therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...